Fortress Biotech, Inc. (FBIOP)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Fortress Biotech, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Fortress Biotech, Inc. (FBIOP) has returned 46.58% so far this year and 131.45% over the past 12 months.

Based on dividend-adjusted daily data since Nov 14, 2017, FBIOP's average daily return is +0.07%, while the average monthly return is +1.03%. At this rate, your investment would double in approximately 5.6 years.

Historically, 59% of months were positive and 41% were negative. The best month was Dec 2025 with a return of +37.5%, while the worst month was Jul 2024 at -46.5%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 5 months.

On a daily basis, FBIOP closed higher 50% of trading days. The best single day was Aug 21, 2023 with a return of +37.2%, while the worst single day was Jul 8, 2024 at -54.8%.

Fortress Biotech, Inc. has an annualized alpha of 13.39%, beta of 0.41, and R² of 0.02 versus S&P 500 Index. Calculated based on daily prices since November 15, 2017.

• This stock participated in 51.39% of S&P 500 Index downside but only 32.94% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.41 may look defensive, but with R² of 0.02 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.02 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

FBIOP ranks 89 for risk / return — in the top 89% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Fortress Biotech, Inc. (FBIOP) and compare them to a chosen benchmark (S&P 500 Index).

Fortress Biotech, Inc. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.

The table displays the monthly dividend distributions for Fortress Biotech, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Fortress Biotech, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Fortress Biotech, Inc. was 73.54%, occurring on Oct 15, 2024. The portfolio has not yet recovered.

The current Fortress Biotech, Inc. drawdown is 26.38%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Fortress Biotech, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Fortress Biotech, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.